Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bindu Potugari"'
Autor:
MacKenzie Mayo, MD, Bindu Potugari, MD, Rami Bzeih, DO, Caleb Scheidel, MS, Carolyn Carrera, MD, Richard A. Shellenberger, DO
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1109-1117 (2021)
The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register
Externí odkaz:
https://doaj.org/article/fc11ee3c3d404a7fab924fb48a7cfa76
Publikováno v:
Caspian Journal of Internal Medicine, Vol 10, Iss 4, Pp 472-475 (2019)
Background: Parvimonas micra is a gram-positive anaerobe and a part of the normal commensal flora of the gastrointestinal tract. Factors predisposing to anaerobic bacteremia include malignant neoplasms, periodontal disease, immune deficiencies, chron
Externí odkaz:
https://doaj.org/article/81d69ea4448f4c40a6c992646e174527
Autor:
Monika A. Izano, Connor Sweetnam, Chenan Zhang, James L. Weese, Douglas Reding, Jonathan Treisman, Anand Patel, Bindu Potugari, Andrew Stafford, Frank M. Wolf, Mary Tran, Thomas D. Brown, Shirish M. Gadgeel
Publikováno v:
Clinical Lung Cancer. 24:362-365
Autor:
Jenna Brown, Bindu Potugari, Marshall A. Mazepa, Ruhail Kohli, Alison R. Moliterno, Robert A. Brodsky, Jason A. Vaught, Richard Burwick, Shruti Chaturvedi
Publikováno v:
Annals of Hematology. 101:2159-2167
Autor:
Richard A. Shellenberger, MacKenzie Mayo, Carolyn Carrera, Bindu Potugari, Rami Bzeih, Caleb Scheidel
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1109-1117 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective: To assess the impact of measures designed to mitigate the spread of COVID-19 on worldwide cancer screening. Patient and Methods: We systematically searched PubMed.gov, Ovid Medline, the Cochrane COVID-19 study register, ClinicalTrials.gov,
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5827, p 5827 (2021)
Cancers, Vol 13, Iss 5827, p 5827 (2021)
Simple Summary Immunotherapy has played a pivotal role in the management of relapsed DLBCL. Stem cell transplant and CAR T-cell therapy are curative treatment modalities for relapsed disease. Despite this, a subset of patients continues to progress,
Autor:
Alexis Nguyen, Misako Nagasaka, Sai-Hong Ignatius Ou, Bindu Potugari, Asfar S. Azmi, Ammar Sukari
Publikováno v:
Cancer treatment reviews. 101
Kirsten rat sarcoma viral oncogene homolog (KRAS) is a proto-oncogene of the RAS-MAPK pathway. KRAS mutations are present in a variety of malignancies including lung, colorectal, and pancreatic cancer. Until the recent approval of sotorasib, a KRAS G